- 大会
- 英卡思亚洲年会 - 2025年 6月
- 英卡思中国大会 - 2025年 7月
- 英卡思巴黎国际年会 - 2026年 1月
- 英卡思美洲年会 - 2026年 3月
- 大师精品课
- 英卡思印度大会 - 2025年 11月
- 大会
- 英卡思亚洲年会 - 2025年 6月
- 英卡思中国大会 - 2025年 7月
- 英卡思巴黎国际年会 - 2026年 1月
- 英卡思美洲年会 - 三月 2026
- 大师精品课
- 英卡思印度大会 - 2025年 11月

英卡思学院

注册新账号

介绍
注册
大会日程
讲者
至尊晚宴
英卡思个人参会日程
赞助企业名单
认证

回到上页

2025 英卡思亚洲年会
大会日程

针对您所在时区的直播课程/会议的时间

时区参照: (UTC+07:00) Asia, Bangkok

时区

时区:改换时区

If you are logged in, change your default time zone in your account

Contributed Talks: Hair restoration

会议室： Room 5 - Level 2
日期： 2025年 6月 8日星期日从 15:00 至 16:00
组织形式： 投稿演讲 > 基于对提交的演示文稿摘要的审核，学术委员会通过的投稿演讲。

主席

Suparuj LUEANGARUN 医师

内科医生

泰国

Chuchai TANGLERTSAMPAN 医师

皮肤科医师

泰国

本场演讲内容

小时	讲者	演讲标题	讲稿摘要	数字
15:00	Rafael FORTUS 医师	Gender-affirming hair restoration	查看	147178
15:12	Fatemeh MOEINEDDIN 医师	Efficacy of microneedling with exosome treatment of androgenetic alopecia: A clinical study on 72 patients	查看	147179
15:24	Arman MOHAMMADI 医师	Novel dual-modality therapy in androgenetic alopecia: Randomized parallel-group trial of Er:Glass 1540 nm plus microneedling VS microneedling alone	查看	147180
15:36	Christopher Toshihiro WIRYA 医师	Managing androgenetic alopecia in aesthetic practice: Practical, evidence-based treatment strategies	查看	150287
15:48		Q&A		147181

进入前一场会议

进入下一场会议

推荐会议

脱发

外泌体

激光

毛发移植

家用设备

Rafael FORTUS 医师

医师

菲律宾

其他作者 :

Gender-affirming hair restoration

Objectives: 1. Develop a holistic and comprehensive approach to gender-affirming hair transplantation.
2. Identify the common gender-affirming features of hairline, eyebrow and beard transplantation.
3. Understand the key surgical, medical and structural factors that mitigate risk and improve patient satisfaction.

Introduction: Hairlines and hairstyles have long defined masculinity and femininity, hair transplantation is an effective and permanent solution to affirming a person’s gender identity. A careful history is required with open-questioned approach to gender identity and goals. There are surgical, medical and structural factors that should be managed to mitigate risk and improve aesthetic outcomes.

Materials / method: For transgender women, hairline designs should be rounder and close the temporal angles, with a soft ‘feathered’ edge. For transgender men, hair transplants can create thicker eyebrows and beards can be designed for facial masculinization.

Surgical sequencing is important; recent breast augmentation of hyoid shaving may preclude prone positioning for hair transplantation. Exogenous testosterone may cause hairline recession in transgender men, a typical male feature, though some will want this corrected while maintaining a masculine hairline.

Results: The success of gender affirming hair transplants is underpinned by proper technique- extractions that do to leave the donor zone scant, hair graft processing to ensure high percentage of graft survival, and implantation that follows direction, desired densities, and design. Post operative care between the genders is similar, though Finasteride should be reserved for biological males.

The presentation includes real-case examples and photos of hairline feminization, eyebrow implantation for both males and females and beard design variability.

Conclusion: Some patients do not fall in the binary gender classifications, so understanding the patient’s goals is more important than classifying their gender. Therefore ‘feminization of the hairline’ may not always be the appropriate term; some patients may prefer a more mathematical or purely aesthetic approach. Transitioning between genders is a non-linear process. Proper surgical planning and medical support can improve outcomes and patient satisfaction.

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。

Fatemeh MOEINEDDIN 医师

皮肤科医师

阿拉伯联合酋长国

其他作者 :

Efficacy of microneedling with exosome treatment of androgenetic alopecia: A clinical study on 72 patients

Objectives: This study investigates the efficacy and safety of microneedling combined with a single administration of 1 cc exosomes in patients with AGA.

Introduction: Androgenetic alopecia (AGA) is a prevalent condition characterized by progressive hair thinning. Emerging regenerative therapies, including microneedling and exosome-based treatments, have shown promise in stimulating hair regrowth. This study investigates the efficacy and safety of microneedling combined with a single administration of 1 cc exosomes in patients with AGA.

Materials / method: Seventy-two patients (48 males, 24 females) with AGA received three sessions of microneedling at four-week intervals. A single dose of 1 cc exosomes was applied topically during the first session. Hair density and thickness were evaluated using digital trichoscopy at baseline and 12 weeks post-treatment. Global photographic assessment and patient satisfaction scores were recorded. Adverse events were monitored.

Results: Significant improvements in hair density and thickness were observed at 12 weeks compared to baseline (p < 0.05). Global photographic evaluations indicated moderate to marked improvement in 73% of patients. Patient-reported satisfaction was high, with 80% noting visible hair regrowth. Side effects were minimal, including transient erythema and mild discomfort . No severe adverse reactions were reported.

Conclusion: A single application of 1 cc exosomes combined with three microneedling sessions is a promising and well-tolerated approach for treating AGA. Further studies with extended follow-ups are recommended to determine long-term efficacy and optimize treatment protocols.

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。

Arman MOHAMMADI 医师

医师

伊朗

其他作者 : Ahmad Nazari MD

Novel dual-modality therapy in androgenetic alopecia: Randomized parallel-group trial of Er:Glass 1540 nm plus microneedling VS microneedling alone

Objectives: This study compares the therapeutic outcomes of combining a 1540 nm erbium:glass fractional laser with microneedling versus microneedling alone for moderate androgenetic alopecia. The primary aim is to determine whether fractional photothermal stimulation augments hair density, follicle diameter, and overall scalp coverage beyond what microneedling alone can achieve, while maintaining an acceptable safety profile in both male and female participants.

Introduction: Androgenetic alopecia is a prevalent, progressive condition affecting men and women, characterized by hormonal sensitivity and gradual follicular miniaturization. Recent evidence highlights the regenerative potential of controlled dermal injury, via microneedling or non-ablative laser, in stimulating hair follicle stem cells. However, data remain scarce regarding the synergistic effect of combining these techniques to maximize hair regrowth and improve scalp coverage in moderate disease severity.

Materials / method: A randomized, parallel-group trial enrolled 26 adults with moderate androgenetic alopecia, divided equally into two arms. Group A received three monthly sessions of a 1540 nm erbium:glass fractional laser applied to the scalp immediately followed by microneedling; Group B underwent identical microneedling but without laser. Digital trichoscopy assessed hair density (hairs/cm²) and shaft thickness at baseline and two months post-final session. Safety outcomes were recorded at each visit.

Results: Compared to baseline, Group A showed a significantly greater rise in hair density (mean +18.2%±3.4) than Group B (mean +9.4%±2.8; p<0.01). Follicle diameter likewise increased more in Group A (+16.1%±2.7) versus Group B (+8.5%±2.3; p<0.05). Photographic and trichoscopic evaluations revealed notably improved scalp coverage in the combination group. Mild erythema was observed in both cohorts, resolving within 24–48 hours, with no serious adverse events reported.

Conclusion: Adding a 1540 nm erbium:glass fractional laser to microneedling confers superior hair regrowth outcomes compared to microneedling alone in moderate androgenetic alopecia. Enhanced follicular stimulation appears to result from synergistic dermal remodeling and localized growth factor release. This minimally invasive combination was well tolerated, suggesting its promise as a next-level approach. Further research with larger cohorts and extended follow-up is warranted to validate and optimize these findings.

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。

Christopher Toshihiro WIRYA 医师

皮肤科医师

印度尼西亚

其他作者 :

Managing androgenetic alopecia in aesthetic practice: Practical, evidence-based treatment strategies

Objectives: This session aims to simplify the management of androgenetic alopecia in aesthetic practice. learn to identify common patterns of hair loss, choose safe and effective treatments including low-dose Finasteride, combine therapies like PRP and microneedling, structure 3–6 month treatment plans, and improve patient communication to boost adherence and satisfaction.

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。

Q&A

大会

N O W

在泰国曼谷

您有问题要问？

在我们的常见问题解答中快速找到答案

大会

英卡思亚洲年会
英卡思中国大会
英卡思巴黎国际年会
英卡思美洲年会

关于我们

公司
隐私政策
法律信息

学院

主页
课程
Webinars
探索
博客

支援

教育援助

保持联系

联系我们

登录名/电邮地址

密码

保持登录状态

密码遗失 ? 还没有账号？现在注册

保持登录状态

academy.Do_not_have_an_account_yet 现在注册

2025 英卡思亚洲年会 大会日程

Contributed Talks: Hair restoration

主席

本场演讲内容

推荐会议

2025 英卡思亚洲年会
大会日程

本场演讲内容